Entering text into the input field will update the search result below

Mersana Therapeutics EPS beats by $0.02, misses on revenue

Aug. 08, 2019 6:08 AM ETMersana Therapeutics, Inc. (MRSN) StockMRSNBy: Pranav Ghumatkar, SA News Editor
  • Mersana Therapeutics (NASDAQ:MRSN): Q2 GAAP EPS of -$0.36 beats by $0.02.
  • Revenue of $0.2M (-95.2% Y/Y) misses by $0.54M.
  • Press Release

Recommended For You

More Trending News

About MRSN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRSN--
Mersana Therapeutics, Inc.